福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.61 (2015) >
このアイテムの引用には次の識別子を使用してください:
http://ir.fmu.ac.jp/dspace/handle/123456789/487
|
タイトル: | Membrane type 1-matrix metalloproteinase (MT1-MMP) identified as a multifunctional regulator of vascular responses |
著者: | Ohkawara, Hiroshi Ikeda, Kazuhiko Ogawa, Kazuei Takeishi, Yasuchika |
学内所属: | 循環器・血液内科学講座 |
誌名/書名: | Fukushima Journal of Medical Science |
巻: | 61 |
号: | 2 |
開始ページ: | 91 |
終了ページ: | 100 |
発行日: | 2015年 |
抄録: | Membrane type 1-matrix metalloproteinase (MT1-MMP) functions as a signaling molecules in addition to a transmembrane metalloprotease, which degrades interstitial collagens and extracellular matrix components. This review focuses on the multifunctional roles of MT1-MMP as a signaling molecule in vascular responses to pro-atherosclerotic stimuli in the pathogenesis of cardiovascular diseases. First, the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1)-MT1-MMP signaling axis contributes to endothelial dysfunction, which is mediated via small GTP-binding protein RhoA and Rac1 activation. Second, MT1-MMP plays a crucial role in reactive oxygen species (ROS) generation through the activation of receptor for advanced glycation end products (AGEs) in smooth muscle cells, indicating that MT1-MMP may be a therapeutic target for diabetic vascular complications. Third, MT1-MMP is involved in RhoA/Rac1 activation and Ca^{2+} signaling in the mechanism of thrombin-stimulated endothelial dysfunction and oxidant stress. Fourth, the inhibition of the MT1-MMP/Akt signaling pathway may be an attractive strategy for treating endothelial disordered hemostasis in the development of vascular diseases linked to TNF-α-induced inflammation. Fifth, MT1-MMP through RAGE induced RhoA/Rac1 activation and tissue factor protein upregulation through NF-κB phosphorylation in endothelial cells stimulated by high-mobility group box-1, which plays a key role in the systemic inflammation. These findings suggest that the MT1-MMP-mediated signaling axis may be a promising target for treating atherosclerosis and subsequent cardiovascular diseases. |
出版者: | The Fukushima Society of Medical Science |
出版者(異表記): | 福島医学会 |
本文の言語: | eng |
このページのURI: | http://ir.fmu.ac.jp/dspace/handle/123456789/487 |
本文URL: | http://ir.fmu.ac.jp/dspace/bitstream/123456789/487/1/FksmJMedSci_61_p91.pdf |
ISSN: | 0016-2590 2185-4610 |
DOI: | 10.5387/fms.2015-15 |
PubMed番号: | 26370683 |
関連ページ: | http://doi.org/10.5387/fms.2015-15 |
権利情報: | © 2015 The Fukushima Society of Medical Science |
出現コレクション: | Vol.61 (2015)
|
このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。
|